The role of intravitreal ranubizumab in the treatment of familial exudative vitreoretinopathy of stage 2 or greater.

about

The role of intravitreal ranubizumab in the treatment of familial exudative vitreoretinopathy of stage 2 or greater.

Item

http://www.wikidata.org/entity/Q55491252

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

The role of intravitreal ranub ...... nopathy of stage 2 or greater.

@en

The role of intravitreal ranub ...... nopathy of stage 2 or greater.

@nl

type

Item

label

The role of intravitreal ranub ...... nopathy of stage 2 or greater.

@en

The role of intravitreal ranub ...... nopathy of stage 2 or greater.

@nl

prefLabel

The role of intravitreal ranub ...... nopathy of stage 2 or greater.

@en

The role of intravitreal ranub ...... nopathy of stage 2 or greater.

@nl

P1476

The role of intravitreal ranub ...... nopathy of stage 2 or greater.

@en

P2093

Guang-Da Deng

http://www.w3.org/2001/XMLSchema#string

Hong Yan

http://www.w3.org/2001/XMLSchema#string

Jing-Hua Liu

http://www.w3.org/2001/XMLSchema#string

Yue-Zhu Lu

http://www.w3.org/2001/XMLSchema#string

P2860

The effects of a treatment combination of anti-VEGF injections, laser coagulation and cryotherapy on patients with type 3 Coat's disease.

Bevacizumab for Coats' disease with exudative retinal detachment and risk of vitreoretinal traction.

Intravitreal bevacizumab injections combined with laser photocoagulation for adult-onset Coats' disease.

Wnt/beta-catenin pathway.

Wnt/frizzled signaling during vertebrate retinal development.

Anti-Vascular Endothelial Growth Factor Therapy for Primary Treatment of Type 1 Retinopathy of Prematurity: A Report by the American Academy of Ophthalmology.

Ranibizumab Injection as Primary Treatment in Patients with Retinopathy of Prematurity: Anatomic Outcomes and Influencing Factors.

Diversity of retinal vascular anomalies in patients with familial exudative vitreoretinopathy.

Assessment of Lower Doses of Intravitreous Bevacizumab for Retinopathy of Prematurity: A Phase 1 Dosing Study.

Resolution of severe macular edema in adult coats' disease with intravitreal triamcinolone and bevacizumab injection.

P304

976-980

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18240/IJO.2018.06.13

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-06-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29977810

http://www.w3.org/2001/XMLSchema#string

P932

6010383

http://www.w3.org/2001/XMLSchema#string